4
Changes in Ownership
agilon health, inc. Filed Acc 0001209191-22-043105
Chief Strategy & Dev. Officer sold 79,768 shares at $27.50 ($2,193,620)
- Chief Strategy & Dev. Officer acquired 79,768 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Desai Veeral Chief Strategy & Dev. Officer | 2022-07-21 | Option exercise | +79,768 | $1.00 | $79,768 | 357,979 | D: show line 1 in the form |
| Desai Veeral Chief Strategy & Dev. Officer | 2022-07-21 | Sale | −79,768 | $27.50 | $2,193,620 | 278,211 | D: show line 2 in the form |
| Open-market sales · 79,768 sh · avg $27.50 · $2,193,620 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Desai Veeral Chief Strategy & Dev. Officer | 2022-07-21 | Option exercise · Options (Rights to Buy) | −79,768 | 57,441 | D: show line 3 in the form |
Loading xslF345X03/doc4.xml…